RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
 Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Feb 19, 2013 - 1:22:36 AM
News Report
Medical News Channel

subscribe to Medical News newsletter
Medical News

   EMAIL   |   PRINT
Sudan scientist asks India for drug to treat leishmaniasis

Nov 24, 2012 - 1:02:18 PM
With 30,000 to 40,000 cases of visceral leishmaniasis recorded per year in the East African region and drug resistance on the increase, the search for alternatives is of paramount importance.

 
[RxPG] Kolkata, Nov 24 - A leading Sudanese scientist has asked India to keep supplying the drug SSG, the only option available to treat leishmaniasis in the East African nation. Leishmaniasis is a disease spread by the bite of the female sandfly.

Keep supplying the drug as it is the only option we have. The other drugs are too expensive or are not as effective, Ahmed Musa of the Institute of Endemic Diseases, University of Khartoum, Sudan, said here Friday.

He was speaking at a global meeting titled 'Hundred Years of Antimonials' at the Indian Institute of Chemical Biology - in Kolkata.

Drug SSG, shown to be 93 percent effective, is supplied by India to the African nation and is well accepted by patients, who are mostly children.

According to the expert, leishmaniasis in East Africa is caused by the same parasitic species which is responsible for the disease in India, although the clinical forms of the disease are different in the two countries.

With 30,000 to 40,000 cases of visceral leishmaniasis recorded per year in the East African region and drug resistance on the increase, the search for alternatives is of paramount importance.

Look for oral alternatives which are affordable and effectivity should not be less than 90 percent, Musa said.



Related Medical News News
Gogoi announces Rs.5 lakh each to HIV victims, four officials suspended
Woman's complain against hospital dismissed
Apollo Hospital offers senior citizens only OPD
New mental health bill bans electric shocks, gives right to treatment
Caution: Eating Goan frog legs could cause cancer
Assam town protests blood bank's HIV 'mistake'
'Collaboration key to addressing problems of disabled'
Mumbai gets special cancer centre for women
Assam blood bank accused of spreading HIV virus
Re-build society with safe blood transfusion: A.K. Walia

Subscribe to Medical News Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)